• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

Recent Advances in the Study of 6-Methyl-2-(methylamino)pyrimidine-4-carboxylic acid (CAS: 915140-72-6)

6-Methyl-2-(methylamino)pyrimidine-4-carboxylic acid (CAS: 915140-72-6) is a pyrimidine derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. Recent studies have focused on its synthesis, physicochemical properties, and biological activities, particularly as a key intermediate or scaffold in the design of novel therapeutic agents.

A study published in the Journal of Medicinal Chemistry (2023) explored the use of 6-Methyl-2-(methylamino)pyrimidine-4-carboxylic acid as a building block for the synthesis of kinase inhibitors. The research demonstrated that modifications at the 4-carboxylic acid position could enhance binding affinity to specific kinase targets, such as EGFR and HER2, which are critical in cancer therapy. The compound's structural flexibility allows for the introduction of various pharmacophores, making it a versatile candidate for further optimization.

Another significant development was reported in Bioorganic & Medicinal Chemistry Letters (2024), where researchers investigated the compound's role in the development of antimicrobial agents. The study highlighted that 6-Methyl-2-(methylamino)pyrimidine-4-carboxylic acid derivatives exhibited potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The findings suggest that this scaffold could be a promising starting point for the design of new antibiotics to address the growing issue of antimicrobial resistance.

In addition to its therapeutic potential, recent advancements in synthetic methodologies have improved the efficiency of producing 6-Methyl-2-(methylamino)pyrimidine-4-carboxylic acid. A 2024 study in Organic Process Research & Development detailed a scalable and environmentally friendly synthesis route, reducing the reliance on hazardous reagents and minimizing waste generation. This progress is crucial for facilitating large-scale production and further pharmacological evaluation.

Overall, the ongoing research on 6-Methyl-2-(methylamino)pyrimidine-4-carboxylic acid underscores its importance as a multifunctional scaffold in medicinal chemistry. Its applications span from oncology to infectious diseases, and its synthetic accessibility makes it an attractive candidate for future drug development efforts. Continued exploration of its derivatives and mechanisms of action is expected to yield novel therapeutic agents with improved efficacy and safety profiles.

• 2164-65-0(2-Aminopyrimidine-4-carboxylic acid)
• 933759-45-6(2-(Dimethylamino)pyrimidine-4-carboxylic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)